Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual versus oral atropine pharmacokinetics for hypersalivation
ACTRN12618001817235Phase 2Completed
- Sponsor
- Sydney Local Health District
- Start
- Aug 2020
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of atropine in hypersalivation, sponsored by Sydney Local Health District. Started Aug 2020; status: completed.
02
Drugs
atropine
03
Conditions
hypersalivation
Beyond the preview
Go deeper on ACTRN12618001817235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001817235.